Cargando…

Active surveillance and clinical analysis of anaphylaxis based on the China Hospital Pharmacovigilance System

Objective: This study aimed to develop active surveillance programs (ASPs) for anaphylaxis using the China Hospital Pharmacovigilance System (CHPS) and analyze the characteristics, allergens, and management strategies for anaphylaxis within a tertiary hospital setting in China. Methods: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chengcheng, Li, Zejing, Yu, Yingying, Feng, Maoyan, Liu, Anchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366353/ https://www.ncbi.nlm.nih.gov/pubmed/37497105 http://dx.doi.org/10.3389/fphar.2023.1180685

Ejemplares similares

Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)
por: Lombardi, Niccolò, et al.
Publicado: (2020)

Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database
por: Liu, Wensheng, et al.
Publicado: (2023)

An update on the Pharmacovigilance Programme of India
por: Lihite, Ratan J., et al.
Publicado: (2015)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Assessment of the Current State of Pharmacovigilance System in Pakistan Using Indicator-Based Assessment Tool
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022)

A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
por: Li, Xiaotong, et al.
Publicado: (2022)

Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database
por: Zhao, Ying, et al.
Publicado: (2017)

Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing
por: Park, Kyung Hee, et al.
Publicado: (2018)

A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022)

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
por: Filippi-Arriaga, Francesca, et al.
Publicado: (2023)

Clinical Data Analytics With Time-Related Graphical User Interfaces: Application to Pharmacovigilance
por: Ledieu, Thibault, et al.
Publicado: (2018)

Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system
por: Jiang, Tingting, et al.
Publicado: (2022)

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
por: Allouchery, Marion, et al.
Publicado: (2021)

Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
por: Gossell-Williams, Maxine, et al.
Publicado: (2022)

Editorial: Reducing the Harm of Medication–Recent Trends in Pharmacovigilance
por: Ramírez, Elena, et al.
Publicado: (2022)

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies
por: Bromley, R. L., et al.
Publicado: (2023)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)
por: Chrétien, Basile, et al.
Publicado: (2023)

Pharmacovigilance Bibliometrics: Visualizing Thematic Development in the Category of Pharmacology and Pharmacy in Web of Science
por: Wang, Li, et al.
Publicado: (2021)

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
por: Zhou, Jianxing, et al.
Publicado: (2022)

Patients’ perception of the pharmacovigilance system: A pre-diagnostic and post-interventional cross-sectional survey
por: Rehman, Atta Ur, et al.
Publicado: (2022)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
por: Wu, Yan, et al.
Publicado: (2023)

Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data
por: Xing, Yan, et al.
Publicado: (2017)

Spinacetin Suppresses the Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mouse Model
por: Ji, Ning, et al.
Publicado: (2018)

The Role of an Interventional Program for Improving Pharmacovigilance at a Pediatric Facility
por: Kronenfeld, Nirit, et al.
Publicado: (2019)

Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes
por: Bui, T-V., et al.
Publicado: (2021)

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS
por: Feng, Zhen, et al.
Publicado: (2022)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020)

Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
por: Khouri, Charles, et al.
Publicado: (2021)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023)

Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study
por: Li, Huixia, et al.
Publicado: (2023)

Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS
por: Zhou, Xiang, et al.
Publicado: (2021)

Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database
por: Wan, Qing, et al.
Publicado: (2022)

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database
por: Zhou, Shuang, et al.
Publicado: (2022)

Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate
por: Chen, Xiaoyi, et al.
Publicado: (2018)

Engaging Patients via Online Healthcare Fora: Three Pharmacovigilance Use Cases
por: Powell, Greg, et al.
Publicado: (2022)

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
por: Wolff, Jan, et al.
Publicado: (2021)

Chlorpheniramine-induced anaphylaxis: Two case reports and a retrospective review of pharmacovigilance database
por: Lee, So-Hee, et al.
Publicado: (2019)

Psychiatric adverse reactions to non-selective RET multi-kinase inhibitors: a large-scale pharmacovigilance analysis
por: Wang, Xuyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bu7hsdgh89c4nrb19e02gc7355